Titlebook: Nutrition and Biotechnology in Heart Disease and Cancer; John B. Longenecker,David Kritchevsky,Marc K. Drez Book 1995 The Editor(s) (if ap

揭發(fā)

書目名稱Nutrition and Biotechnology in Heart Disease and Cancer影響因子(影響力)




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer影響因子(影響力)學(xué)科排名




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer網(wǎng)絡(luò)公開度




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer被引頻次




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer被引頻次學(xué)科排名




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer年度引用




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer年度引用學(xué)科排名




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer讀者反饋




書目名稱Nutrition and Biotechnology in Heart Disease and Cancer讀者反饋學(xué)科排名

價值在貶值

Signal Transduction in Atherosclerosis: Second Messengers and Regulation of Cellular Cholesterol Traas a chronic inflammatory response to high concentrations of native or modified low density lipoprotein (LDL), which in turn elicits a series of cellular and biochemical events which result in alterations in endothelial cell phenotype, macrophage infiltration, smooth muscle cell migration, prolifera

狂熱語言

杠桿支點(diǎn)

Impact of Biotechnology in the Diagnostic and Therapeutic Management of Cardiovascular Disordersve to be useful in the management of antithrombotic disorders. Although the use of transgenic animals is still at experimental stages, the initial findings are promising and will provide important leads into the development of therapeutic proteins. Through biotechnology, recombinant inhibitors of fi

dearth

債務(wù)

貪婪性

猛烈責(zé)罵

Gardner C. McMillane of many Ets target genes in transformation. A better understanding of the role of Ets factors and their target genes in cancer should provide the basis for more specific novel therapeutic approaches for the treatment of cancers.

軟膏

Herman A. Tyrolere of many Ets target genes in transformation. A better understanding of the role of Ets factors and their target genes in cancer should provide the basis for more specific novel therapeutic approaches for the treatment of cancers.

upstart

Kenneth B. Pomerantz,Andrew C. Nicholson,David P. Hajjar seems to be the leading factor in controlling the regulation of the promoter. Therefore, by engineering these elements, different types of promoters such as inducible promoters, tissue-spatial specific promoters, and constitutive promoters can be developed and used to drive various pathogen resistance genes.